CVS Health Corporation (CVS) Stock Price: $97.06-0.02 (-0.02%)
The total return cagr for CVS Health Corporation (CVS) stock is 57.52% over the past 12 months. The 3 year average growth rate is 14.93% and the 5 year cagr is 6.15%. Total return includes dividends reinvested.
The closing share price for CVS Health Corporation (CVS) stock was $97.06 for Tuesday, June 9, 2026, down -0.02% from the previous day.
CVS Price Chart
CVS Key Metrics
See All MetricsCVS Earnings Preview
Next Earnings Date
Jul 30, 2026
51 days away
EPS Estimate
1.83
Revenue Est.
$100.17B
Last Quarter Results
EPS
$2.57
vs Estimate
$2.21
Revenue
$100.43B
vs Estimate
$94.99B
CVS Analyst Ratings
Consensus Rating
Based on 26 analysts
Average Price Target
$103.81
+7.0% upside
Low
$79.00
Current
$97.06
High
$140.00
CVS Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $2.76 | N/A | 10 |
| Q2 2027 | N/A | $2.10 | N/A | 6 |
| Q3 2027 | N/A | $1.98 | N/A | 7 |
| Q4 2027 | N/A | $1.56 | N/A | 6 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $8.38 | N/A | 17 |
| FY 2028 | N/A | $9.64 | N/A | 10 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $103.54B | N/A | 10 |
| Q2 2027 | N/A | $103.96B | N/A | 6 |
| Q3 2027 | N/A | $107.33B | N/A | 7 |
| Q4 2027 | N/A | $110.29B | N/A | 6 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $425.29B | N/A | 17 |
| FY 2028 | N/A | $448.67B | N/A | 10 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
CVS Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1CVS | $123.84B | $97.06 | -0.02% | +57.52% | +6.15% | +3.12% |
CVS Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt